Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014
- 17 December 2015
- journal article
- Published by Informa UK Limited in The American Journal of Drug and Alcohol Abuse
- Vol. 42 (1), 39-47
- https://doi.org/10.3109/00952990.2015.1106551
Abstract
Background: Novel psychoactive substances (NPS) are emerging at an unprecedented rate. Likewise, prevalence of use and poisonings has increased in recent years. Objective: To compare characteristics of NPS exposures and non-NPS-drug-related exposures and to examine whether there are differences between exposures involving synthetic cannabinoid receptor agonists (SCRAs) and other NPS. Methods: Poison control center data from the five counties of New York City and Long Island were examined from 2011–2014. We examined prevalence and characteristics of NPS exposures (classified as intentional abuse) and compared characteristics of cases involving SCRAs and other NPS. Results: Prevalence of NPS exposures was 7.1% in 2011, rising to 12.6% in 2014. Most exposures (82.3%) involved SCRA use. The second and third most prevalent classes were phenethylamines/synthetic cathinones (“bath salts”; 10.2%) and psychedelic phenethylamines (4.3%). Compared to other drug-related exposures (i.e. involving licit and illicit drugs), those who used NPS were more likely to be younger, male, and to have not co-used other drugs (ps < 0.001). SCRA exposures increased sharply in 2014 and the mean age of users increased over time (p < 0.01). Females exposed to SCRAs were younger than males (p < 0.001), and in 2014, individuals exposed to SCRAs were more likely to report concomitant use of alcohol than users of other NPS (p = 0.010). Users of other NPS were more likely than SCRA users to report concomitant use of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)/“Molly” (p < 0.001). Conclusion: Exposures reported to the poison center that involve NPS are increasing and the majority involve SCRAs. These findings should inform prevention and harm reduction approaches.Keywords
Funding Information
- National Institutes of Health (K01 DA-038800)
This publication has 27 references indexed in Scilit:
- Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreportingDrug and Alcohol Dependence, 2015
- Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use — United States, January–May 20152015
- Novel psychoactive substances of interest for psychiatryWorld Psychiatry, 2015
- NBOMe Designer Drug Exposures Reported to Texas Poison CentersJournal of Addictive Diseases, 2014
- Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.2014
- Clinical and pharmacological aspects of bath salt use: A review of the literature and case reportsDrug and Alcohol Dependence, 2013
- Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA projectScandinavian Journal of Clinical and Laboratory Investigation, 2013
- 2C Series Phenethylamine Derivative Exposures in TexasSubstance Abuse, 2013
- 2011 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual ReportClinical Toxicology, 2012
- Ecstasy use among US adolescents from 1999 to 2008Drug and Alcohol Dependence, 2010